Abstract
Intensive research of hematopoiesis using human embryonic stem cells (hESC) as a unique starting cell population has enabled differentiation and isolation of diverse hematopoietic cell lineages. However, there has been only limited success in derivation of hematopoietic stem cells (HSCs) capable of long-term, multi-lineage engraftment when transplanted into xenogeneic models. Better understanding of the HSC developmental niche, the home for hematopoietic stem and progenitor cells, will aid to advance strategies to derive and assay putative HSCs from hESCs. This review discusses recent status of hematopoietic development from the hESCs and highlights the possibility of developing HSC niche using hESC-derived niche components.
Keywords: Human embryonic stem cell, hematopoiesis, endosteal niche, vascular niche, engraftment
Current Stem Cell Research & Therapy
Title: Use of Human Embryonic Stem Cells to Understand Hematopoiesis and Hematopoietic Stem Cell Niche
Volume: 5 Issue: 3
Author(s): Mohammad Saiful Islam, Zhenya Ni and Dan S. Kaufman
Affiliation:
Keywords: Human embryonic stem cell, hematopoiesis, endosteal niche, vascular niche, engraftment
Abstract: Intensive research of hematopoiesis using human embryonic stem cells (hESC) as a unique starting cell population has enabled differentiation and isolation of diverse hematopoietic cell lineages. However, there has been only limited success in derivation of hematopoietic stem cells (HSCs) capable of long-term, multi-lineage engraftment when transplanted into xenogeneic models. Better understanding of the HSC developmental niche, the home for hematopoietic stem and progenitor cells, will aid to advance strategies to derive and assay putative HSCs from hESCs. This review discusses recent status of hematopoietic development from the hESCs and highlights the possibility of developing HSC niche using hESC-derived niche components.
Export Options
About this article
Cite this article as:
Saiful Islam Mohammad, Ni Zhenya and S. Kaufman Dan, Use of Human Embryonic Stem Cells to Understand Hematopoiesis and Hematopoietic Stem Cell Niche, Current Stem Cell Research & Therapy 2010; 5 (3) . https://dx.doi.org/10.2174/157488810791824467
DOI https://dx.doi.org/10.2174/157488810791824467 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Therapeutic Prospects of PPARs in Psychiatric Disorders: A Comprehensive Review
Current Drug Targets Author Index to Volume 1
Vascular Disease Prevention (Discontinued) Mechanisms of Intimal Hyperplasia Learned from a Murine Carotid Artery Ligation Model
Current Vascular Pharmacology Differential Influence of Carotid Stenosis and White Matter Disease on Motor and Cognitive Activation
Current Alzheimer Research Genetics in Anti-Platelet Treatment
Current Pharmaceutical Design Role of PPAR in Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Emergency Contraception: Current Methods, Usages and Issues
Current Women`s Health Reviews Regulation of Vascular Genes by Glucose
Current Pharmaceutical Design Macrophage Differentiation to Foam Cells
Current Pharmaceutical Design Heat Shock Proteins: Therapeutic Perspectives in Inflammatory Disorders
Recent Patents on Inflammation & Allergy Drug Discovery Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis
Current Genomics Plant Terpenes on Treating Cardiovascular and Metabolic Disease: A Review
Protein & Peptide Letters Gender-Specific Aspects in Primary and Secondary Prevention of Cardiovascular Disease
Current Pharmaceutical Design Benefits of SGLT2 Inhibitors Beyond Glycemic Control – A Focus on Metabolic, Cardiovascular and Renal Outcomes
Current Diabetes Reviews Vitamin D Supplementation and Cancer: Review of Randomized Controlled Trials
Anti-Cancer Agents in Medicinal Chemistry Nano-Systems for Advanced Therapeutics and Diagnosis of Atherosclerosis
Current Pharmaceutical Design Patent Selections
Recent Patents on Biotechnology The Emergent Cardiovascular Risk Factors and Organ Damage in Arterial Hypertension
Current Hypertension Reviews Vascular Contribution to Alzheimer Disease: Predictors of Rapid Progression
CNS & Neurological Disorders - Drug Targets Pleiotropic Beneficial Effects of Epigallocatechin Gallate, Quercetin and Delphinidin on Cardiovascular Diseases Associated with Endothelial Dysfunction
Cardiovascular & Hematological Agents in Medicinal Chemistry